Visfatin Related to the Severity of Non-ST-Segment Elevation Acute Coronary Syndrome: A Retrospective Study of 164 Patients at a Tertiary Chest Pain Center

Table 1

Comparison of clinical data between control group and subgroup of coronary lesions.

Variable	Control (n = 55)	NSTE-ACS (n = 109)			value
		Single-vessel disease group (n = 41)	Double-vessel disease group (n = 28)	Multivessel disease group (n = 40)
Male (n, %)	33 (60.0%)	32 (78.0%)	22 (78.6%)	30 (75.0%)	0.156
Age (years)	66.87 ± 9.45	62.66 ± 11.44	61.43 ± 9.69	66.30 ± 9.49	0.054
Smoking (n, %)	17 (30.9%)	18 (43.9%)	15 (53.6%)	18 (45.0%)	0.208
Diabetes (n, %)	8 (14.5%)	5 (12.2%)	5 (17.9%)	12 (30.0%)	0.180
Hypertension (n, %)	21 (38.2%)	19 (46.3%)	11 (39.3%)	23 (57.5%)	0.273
BMI (kg/m^2)	23.40 (21.90, 25.30)	23.80 (22.05, 26.25)	24.40 (22.60, 25.97)	24.40 (22.01, 26.15)	0.563
Triglycerides (mmol/L)	1.29 (1.01, 1.65)	1.13 (0.84, 1.76)	1.40 (1.03, 1.86)	1.52 (1.14, 1.94)	0.102
Total cholesterol (mmol/L)	4.22 ± 0.91	4.02 ± 0.89	4.29 ± 1.02	4.11 ± 0.96	0.604
High-density lipoprotein-C (mmol/L)	1.17 (0.98, 1.40)	1.07 (0.96, 1.22)	0.96 (0.82, 1.16)	0.92 (0.79, 1.04)	<0.01
Low-density lipoprotein-C (mmol/L)	2.46 (2.05, 2.86)	2.61 (2.09, 2.93)	2.86 (2.18, 3.46)	2.66 (2.05, 3.14)	0.335
Creatinine (μmol/L)	68 (59, 85)	73 (65, 83)	79.5 (70, 93)	79 (68, 98)	0.023

BMI, body mass index.